undamentalytics Newsletter

Dmytruk Mark E.: insider trades

Officer at Ginkgo Bioworks Holdings, Inc. No open-market purchases and 26 sales not made under a pre-set plan, reported from October 4, 2022 to November 6, 2024.

What happened after Dmytruk Mark E.’s sales?

After their sales, the shares moved +17.5% against the index over 12 months on average (a negative figure means selling was the right call); 50% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Dmytruk Mark E.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 2 +34.2% +34.2% 0% 1 — — Not enough years
Sales, 12 months after the report 2 +17.5% +17.5% 50% 1 — — Not enough years
Sales, 12 months after the trade 2 +51.6% +51.6% 0% 1 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Ginkgo Bioworks Holdings, Inc. DNA See remarks026October 4, 2022November 6, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 6, 2024November 4, 2024 DNA Sale $10,021 +45.8%−15.1%+29.0%
October 8, 2024October 4, 2024 DNA Sale $10,162 +22.7%+50.1%+74.3%
August 6, 2024August 2, 2024 DNA Sale $18,434 not yetnot yetnot yet
July 5, 2024July 2, 2024 DNA Sale $16,223 not yetnot yetnot yet
June 5, 2024June 3, 2024 DNA Sale $26,876 not yetnot yetnot yet
May 6, 2024May 2, 2024 DNA Sale $40,635 not yetnot yetnot yet
April 4, 2024April 2, 2024 DNA Sale $53,727 not yetnot yetnot yet
March 6, 2024March 4, 2024 DNA Sale $48,921 not yetnot yetnot yet
February 6, 2024February 2, 2024 DNA Sale $47,878 not yetnot yetnot yet
January 5, 2024January 3, 2024 DNA Sale $70,523 not yetnot yetnot yet
December 6, 2023December 4, 2023 DNA Sale $58,939 not yetnot yetnot yet
November 6, 2023November 2, 2023 DNA Sale $55,844 not yetnot yetnot yet
October 4, 2023October 2, 2023 DNA Sale $74,337 not yetnot yetnot yet
September 6, 2023September 5, 2023 DNA Sale $92,774 not yetnot yetnot yet
August 4, 2023August 2, 2023 DNA Sale $96,294 not yetnot yetnot yet
July 6, 2023July 3, 2023 DNA Sale $73,147 not yetnot yetnot yet
June 6, 2023June 2, 2023 DNA Sale $63,602 not yetnot yetnot yet
May 4, 2023May 2, 2023 DNA Sale $44,622 not yetnot yetnot yet
April 5, 2023April 3, 2023 DNA Sale $49,259 not yetnot yetnot yet
March 16, 2023March 15, 2023 DNA Sale $38,988 not yetnot yetnot yet
February 3, 2023February 2, 2023 DNA Sale $59,961 not yetnot yetnot yet
January 6, 2023January 4, 2023 DNA Sale $53,957 not yetnot yetnot yet
December 5, 2022December 2, 2022 DNA Sale $58,398 not yetnot yetnot yet
November 7, 2022November 3, 2022 DNA Sale $81,101 not yetnot yetnot yet
October 7, 2022October 6, 2022 DNA Sale $907,579 not yetnot yetnot yet
October 4, 2022October 3, 2022 DNA Sale $22,648 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Dmytruk Mark E. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.